The Cancer Panel is a critical component of the MDL Anticancer PlasmaXchange protocol, offering cutting-edge diagnostic capabilities for early cancer detection.
Cancer Panel
Cancer Panel: Advanced Testing for Early Detection
Why Choose the Cancer Panel?
- Early Detection: Earliest method for detecting cancer before symptoms appear.
- Comprehensive Analysis: Detects pre-cancer markers like membrane proteins and Peripheral Blood Mononuclear (PBM) cells and circulating tumor cells (CTCs) which are often the earliest signs of cancer.
- Personalized Insights: Provides actionable data for proactive health decisions.
Tests Included
- Onco-D-Clare: Screens for Peripheral Blood Mononuclear (PBM) cells.
- Oncotrace RGCC: Tracks cancer cell presence and membrane proteins.
